NCT05378256View on ClinicalTrials.gov

Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

March 11, 2025

Study Completion Date

March 11, 2025

Conditions
LymphomaPeripheral Neuropathy
Interventions
OTHER

Clinical scales of CIPN

Patients with lymphoma will be evaluated before chemotherapy (T1), after 4 cycles (T2), at the end of the chemotherapy treatment (If more than 4 cycles) (T3) and 6 month after the end of chemotherapy (T4).

Trial Locations (1)

45067

CHR Orléans, Orléans

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER